Literature DB >> 2550371

Fusion of inclusions following superinfection of HeLa cells by two serovars of Chlamydia trachomatis.

J C Ridderhof1, R C Barnes.   

Abstract

We used a double-label immunofluorescence assay to examine the ability of Chlamydia trachomatis serovar F to infect and develop within HeLa 229 cells previously infected with serovar E. No exclusion to superinfection occurred for up to 24 h following infection by serovar E. The percentage of HeLa cells infected in cultures inoculated with both strains was identical to that of cells in cultures inoculated with one strain as a control. Organisms of both serovars were located within the same intracellular inclusion in 88 to 95% of HeLa cells infected with both serovars. The proportion of superinfected HeLa cells containing both strains in separate inclusions increased when there was exposure to inhibitors of cytoskeletal structure and transport. We used this inhibition to demonstrate that fusion of C. trachomatis phagosomes occurs throughout the developmental cycle.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550371      PMCID: PMC260788          DOI: 10.1128/iai.57.10.3189-3193.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Correlation between morphological and biochemical changes and the appearance of infectivity in FL cell cultures infected with trachoma agent.

Authors:  H BERNKOPF; P MASHIAH; Y BECKER
Journal:  Ann N Y Acad Sci       Date:  1962-03-05       Impact factor: 5.691

2.  Some consequences of the multiple infection of cell cultures by TRIC organisms.

Authors:  W A Blyth; J Taverne
Journal:  J Hyg (Lond)       Date:  1972-03

3.  Purification on renografin density gradients of Chlamydia trachomatis grown in the yolk sac of eggs.

Authors:  L Howard; N S Orenstein; N W King
Journal:  Appl Microbiol       Date:  1974-01

4.  Division of single host cells after infection with chlamydiae.

Authors:  K D Horoschak; J W Moulder
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

5.  Persistent infection of mouse fibroblasts (McCoy cells) with a trachoma strain of Chlamydia trachomatis.

Authors:  C K Lee; J W Moulder
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

6.  Primary isolation of TRIC organisms in HeLa 229 cells treated with DEAE-dextran.

Authors:  C Kuo; S Wang; B B Wentworth; J T Grayston
Journal:  J Infect Dis       Date:  1972-06       Impact factor: 5.226

7.  Fluorescence microscopy: reduced photobleaching of rhodamine and fluorescein protein conjugates by n-propyl gallate.

Authors:  H Giloh; J W Sedat
Journal:  Science       Date:  1982-09-24       Impact factor: 47.728

8.  Effect of methylamine and monodansylcadaverine on the susceptibility of McCoy cells to Chlamydia trachomatis infection.

Authors:  G Söderlund; E Kihlström
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

9.  Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization.

Authors:  R S Stephens; M R Tam; C C Kuo; R C Nowinski
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

10.  Persistent infection of mouse fibroblasts (L cells) with Chlamydia psittaci: evidence for a cryptic chlamydial form.

Authors:  J W Moulder; N J Levy; L P Schulman
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

View more
  30 in total

Review 1.  Interaction of chlamydiae and host cells in vitro.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1991-03

2.  Evolution of Chlamydia trachomatis diversity occurs by widespread interstrain recombination involving hotspots.

Authors:  João P Gomes; William J Bruno; Alexandra Nunes; Nicole Santos; Carlos Florindo; Maria J Borrego; Deborah Dean
Journal:  Genome Res       Date:  2006-11-07       Impact factor: 9.043

Review 3.  Emancipating Chlamydia: Advances in the Genetic Manipulation of a Recalcitrant Intracellular Pathogen.

Authors:  Robert J Bastidas; Raphael H Valdivia
Journal:  Microbiol Mol Biol Rev       Date:  2016-03-30       Impact factor: 11.056

4.  Evidence for naturally occurring recombination in the gene encoding the major outer membrane protein of lymphogranuloma venereum isolates of Chlamydia trachomatis.

Authors:  L J Hayes; P Yearsley; J D Treharne; R A Ballard; G H Fehler; M E Ward
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

5.  Entry and survival of Leishmania amazonensis amastigotes within phagolysosome-like vacuoles that shelter Coxiella burnetii in Chinese hamster ovary cells.

Authors:  P S Veras; C Moulia; C Dauguet; C T Tunis; M Thibon; M Rabinovitch
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  Cytoskeletal requirements in Chlamydia trachomatis infection of host cells.

Authors:  N Schramm; P B Wyrick
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

7.  Trypanosoma cruzi Differentiates and Multiplies within Chimeric Parasitophorous Vacuoles in Macrophages Coinfected with Leishmania amazonensis.

Authors:  Carina Carraro Pessoa; Éden Ramalho Ferreira; Ethel Bayer-Santos; Michel Rabinovitch; Renato Arruda Mortara; Fernando Real
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

8.  Mobilization of F-actin and clathrin during redistribution of Chlamydia trachomatis to an intracellular site in eucaryotic cells.

Authors:  M Majeed; E Kihlström
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

9.  Recombination in the genome of Chlamydia trachomatis involving the polymorphic membrane protein C gene relative to ompA and evidence for horizontal gene transfer.

Authors:  João P Gomes; William J Bruno; Maria J Borrego; Deborah Dean
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

10.  Inclusion biogenesis and reactivation of persistent Chlamydia trachomatis requires host cell sphingolipid biosynthesis.

Authors:  D Kesley Robertson; Ling Gu; Regina K Rowe; Wandy L Beatty
Journal:  PLoS Pathog       Date:  2009-11-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.